Kenya is set to introduce a new HIV prevention injection, Lenacapavir, which will cost Sh6,000 per dose and provide six…
Browsing: PrEP
The World Health Organization (WHO) has introduced updated guidelines for the prevention and management of HIV that aim to transform…
Kenya plans to introduce Lenacapavir, a long‑acting injectable for HIV prevention, beginning in January 2026 a step expected to strengthen…
Kenya is set to become one of the first countries globally to roll out Lenacapavir (LEN), a long-acting injectable drug…
In a groundbreaking development for HIV prevention, a new drug called Yeztugo has been approved as the first-ever twice-yearly injection…
An annual injection designed to protect against Human Immunodeficiency Virus (HIV) has successfully completed an important early safety trial. The…
The HIV prevalence rate among individuals aged 15 to 34 is on the rise, with low condom usage playing a…
Despite decades of global efforts, HIV/AIDS continues to be a significant public health challenge, with millions of people still living…
Australia is currently experiencing a significant shortage of the HIV-prevention drug PrEP (pre-exposure prophylaxis), prompting concerns among health experts and…
In eastern and southern Africa, young women are disproportionately affected by new HIV infections, highlighting a critical public health challenge…